Cover Image

Towards Efficient Time‐to‐Event Dose‐Escalation Guidance of Multi‐Cycle Cancer Therapies

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Lukas A. Widmer, Sebastian Weber, Yunnan Xu, Hans‐Jochen Weber
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Accounting for Carryover Toxicity in Phase I Clinical Trials with Intra‐Patient Dose Escalation
by: Chloe E. Falke, et al.
Published: (2025)

TITE-CLRM: Towards efficient time-to-event dose-escalation guidance of multi-cycle cancer therapies
by: Widmer, Lukas Andreas, et al.
Published: (2024)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
by: Holger Dette, et al.
Published: (2025)

What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies
by: Brennan C. Kahan, et al.
Published: (2026)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
by: Rebecca B. Silva, et al.
Published: (2024)

Efficient Risk Assessment of Time‐to‐Event Targets With Adaptive Information Transfer
by: Jie Ding, et al.
Published: (2024)

COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR‐T Therapies
by: Kai Chen, et al.
Published: (2025)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
by: Yichen Yan, et al.
Published: (2025)

Reverse Time‐to‐Death as Time‐Scale in Time‐to‐Event Analysis for Studies of Advanced Illness and Palliative Care
by: Yin Bun Cheung, et al.
Published: (2025)

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment
by: Daniel Backenroth, et al.
Published: (2026)

Adaptive Weight Selection for Time‐To‐Event Data Under Non‐Proportional Hazards
by: Moritz Fabian Danzer, et al.
Published: (2025)

Predicting Individual Risk of Advanced Adenoma Based on the Interval‐Censored Recurrent Adenoma Event and Informative Screening Time
by: Yipeng Wei, et al.
Published: (2026)

Strategy to Control Biases in Prior Event Rate Ratio Method, With Application to Palliative Care in Patients With Advanced Cancer
by: Xiangmei Ma, et al.
Published: (2026)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
by: Jingyan Fu, et al.
Published: (2025)

Nonparametric Path‐Specific Effects on a Survival Outcome Through Multiple Time‐to‐Event Mediators
by: Yen‐Tsung Huang, et al.
Published: (2025)

Time‐Dependent ROC Curve for Multiple Longitudinal Biomarkers and Its Application in Diagnosing Cardiovascular Events
by: Lizhe Sun, et al.
Published: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025)

Estimating Risk Factors for Pathogenic Dose Accrual From Longitudinal Data
by: Daniel K. Sewell, et al.
Published: (2025)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
by: Yingjie Qiu, et al.
Published: (2026)

Network Meta‐Analysis With Individual Participant‐Level Data of Time‐to‐Event Outcomes Using Cox Regression
by: Kaiyuan Hua, et al.
Published: (2025)

Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes
by: Seungjae Lee, et al.
Published: (2024)

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
by: Florian Klinglmüller, et al.
Published: (2025)

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority
by: Hakim‐Moulay Dehbi, et al.
Published: (2025)

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
by: Marco Ratta, et al.
Published: (2026)

Jointly Modeling Time‐To‐Event and Longitudinal Data With Individual‐Specific Change Points: A Case Study in Modeling Tumor Burden
by: Ethan M. Alt, et al.
Published: (2025)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
by: Xinran Huang, et al.
Published: (2024)

A Bayesian Location‐Scale Joint Model for Time‐To‐Event and Multivariate Longitudinal Data With Association Based on Within‐Individual Variability
by: Marco Palma, et al.
Published: (2026)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
by: David S. Robertson, et al.
Published: (2025)

Sequential Event Rate Monitoring
by: Dong‐Yun Kim, et al.
Published: (2026)

Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time‐To‐Event Outcomes
by: Denis Talbot, et al.
Published: (2025)

A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight
by: Zihan Qian, et al.
Published: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I– II Oncology Dose Finding Trials
by: Andrew Hall, et al.
Published: (2026)

Trivariate Joint Modeling for Family Data with Longitudinal Counts, Recurrent Events and a Terminal Event with Application to Lynch Syndrome
by: Jingwei Lu, et al.
Published: (2024)

Incorporating Heterogeneity in Mixed Hidden Markov Models With an Application to the Sleep‐Wake Cycle
by: Jordan Aron, et al.
Published: (2025)

DOD ‐ SSR : An Adaptive Seamless Phase II / III Design With Dose Optimization Decision and Sample Size Re‐estimation
by: Meizi Liu, et al.
Published: (2025)

BCH‐GEE Approach to Examine the Association Between Time‐Varying Food Environment Classes and Multi‐Level Health Outcomes
by: Kelsey A. L. Alexovitz, et al.
Published: (2026)

Time‐Varying Hormonal Treatment and Metastasis‐Free Survival Among ER+ Breast Cancer Patients: A Natural History Modelling Approach
by: Letizia Orsini, et al.
Published: (2026)

ChatGPT as a Tool for Biostatisticians: A Tutorial on Applications, Opportunities, and Limitations
by: Dennis Dobler, et al.
Published: (2025)

Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study
by: Yunro Chung, et al.
Published: (2025)

Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment
by: Ruiqian Wu, et al.
Published: (2025)